‌

‌

‌

‌

‌‌

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 229 publications

The current clinical trial landscape in idiopathic inflammatory myopathies.

The current clinical trial landscape in idiopathic inflammatory myopathies.

Journal: Current opinion in rheumatology

Published: August 26, 2026

International IVIg prescription patterns in idiopathic inflammatory myopathies: real-world insights from the MyoNet survey.

International IVIg prescription patterns in idiopathic inflammatory myopathies: real-world insights from the MyoNet survey.

Journal: EULAR rheumatology open

Published: June 29, 2026

Assessing the diagnostic performance of the muscle biopsy features in the 2024 ENMC Inclusion Body Myositis Criteria.

Assessing the diagnostic performance of the muscle biopsy features in the 2024 ENMC Inclusion Body Myositis Criteria.

Journal: Rheumatology (Oxford, England)

Published: April 20, 2026

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

Journal: The New England journal of medicine

Published: March 30, 2026

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

Journal: The New England journal of medicine

Published: March 30, 2026

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Journal: Journal of autoimmunity

Published: February 12, 2026

Refining Human Phenotype Ontology (HPO) to enable better phenotype-genotype integration in systemic autoimmune rheumatic diseases.

Refining Human Phenotype Ontology (HPO) to enable better phenotype-genotype integration in systemic autoimmune rheumatic diseases.

Journal: Orphanet journal of rare diseases

Published: January 26, 2026

Assessing the diagnostic utility of baseline creatine kinase levels in patients with suspected idiopathic inflammatory myopathies and neuromuscular disorders.

Assessing the diagnostic utility of baseline creatine kinase levels in patients with suspected idiopathic inflammatory myopathies and neuromuscular disorders.

Journal: Rheumatology advances in practice

Published: January 22, 2026

Urate-lowering effects of losartan: a meta-analysis of randomised controlled trials and target trial emulation.

Urate-lowering effects of losartan: a meta-analysis of randomised controlled trials and target trial emulation.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: January 09, 2026

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Journal: Arthritis care & research

Published: December 08, 2025

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Journal: Arthritis care & research

Published: December 08, 2025

Multi-ancestry genome-wide association study of serum creatine kinase implicates myopathy genes and muscle pathways.

Multi-ancestry genome-wide association study of serum creatine kinase implicates myopathy genes and muscle pathways.

Journal: EBioMedicine

Published: December 03, 2025

Showing 1-12 of 229

Last Updated: 09/26/2026